SculpSure OKed for Back, Inner and Outer Thighs

June 16, 2017

The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure’s SculpSure to treat the back and inner and outer thighs.
The SculpSure treatment is already FDA-cleared for treatment of the abdomen and love handles.
Developed by Cynosure, a division of Hologic, SculpSure utilizes a selective wavelength laser that precisely targets fat cells under the skin. The laser raises the temperature of body fat to disrupt and destroy these cells, which are naturally eliminated over time and do not return. Patients are able to achieve desired results – without downtime or surgery – through customized treatment plans, each lasting only 25 minutes.
Read more at Modern Aesthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides